Hub : Traits :

Smoking status: Previous

20 significantly associated models · 13 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	154401972	155762509	1	1	2.9e-07	1.9e-07	0.2490	95	EFNA1
2	2	47780684	48277490	1	1	1.5e-07	1.5e-07	0.0677	88	MSH6
3	3	84317575	86808226	1	1	8.4e-13	2.1e-13	0.0587	93	CADM2
4	6	110588546	112501537	3	1	9.3e-10	9.4e-11	0.0256	88	GTF3C6
5	7	2646223	5003373	1	1	1.3e-08	7.3e-10	0.0084	82	SDK1
6	12	111193499	113137832	4	1	3.4e-08	1.7e-10	0.0002	66	ALDH2
7	16	69062879	70473934	2	1	4.5e-08	2.1e-07	0.8370	100	NOB1

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder (2018)	1.82	1	0	0.0	0.00	1.0e+00	CADM2
Depressed Affect (Nagel 2018)	2.41	2	0	0.0	0.00	1.0e+00	ALDH2 EFNA1
Depression (Nagel 2018)	2.40	1	0	0.0	0.00	1.0e+00	ALDH2
Intelligence (Savage-Jansen 2018)	1.57	1	0	0.0	0.00	1.0e+00	MSH6
Neuroticism (Nagel 2018)	1.62	1	0	0.0	0.00	1.0e+00	CADM2
Worry (Nagel 2018)	5.90	2	1	2.2	0.00	1.0e+00	CADM2 GTF3C6
Crohns Disease (2017)	2.79	1	1	2.2	0.00	1.0e+00	EFNA1
Irritable Bowel Disease (IBD)	4.16	2	1	2.2	0.00	1.0e+00	ALDH2 EFNA1
Ulcerative Colitis (UC)	3.81	2	0	0.0	0.00	1.0e+00	ALDH2 EFNA1
Reaction Time	3.71	1	1	2.2	0.00	1.0e+00	ALDH2
Breast Cancer	2.02	1	0	0.0	0.00	1.0e+00	EFNA1
Coronary Artery Disease (CAD)	3.31	1	0	0.0	0.00	1.0e+00	ALDH2
Crohns Disease (2012)	2.20	1	0	0.0	0.00	1.0e+00	EFNA1
Fasting Glucose	2.56	1	0	0.0	0.00	1.0e+00	MSH6
LDL Cholesterol	4.51	1	1	2.2	0.00	1.0e+00	ALDH2
Lupus	2.02	1	0	0.0	0.00	1.0e+00	ALDH2
Primary Biliary Cirrhosis	2.99	1	0	0.0	0.00	1.0e+00	ALDH2
Rheumatoid Arthritis	1.96	1	0	0.0	0.00	1.0e+00	ALDH2
Ulcerative Colitis	1.84	1	0	0.0	0.00	1.0e+00	EFNA1
Blood Eosinophil Count	18.63	2	1	2.2	0.00	1.0e+00	ALDH2 GTF3C6
Blood Platelet Count	2.94	4	3	6.7	0.79	2.1e-01	ALDH2 EFNA1 MSH6 NOB1
Blood Red Count	5.25	3	3	6.7	0.00	1.0e+00	ALDH2 EFNA1 GTF3C6
Blood White Count	8.95	1	1	2.2	0.00	1.0e+00	ALDH2
Heel T-Score	1.43	3	1	2.2	0.00	1.0e+00	EFNA1 MSH6 NOB1
BMI	3.63	5	1	2.2	0.47	4.2e-01	ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Height	0.44	2	1	2.2	0.00	1.0e+00	ALDH2 NOB1
Waist Hip Ratio (WHR)	1.83	3	0	0.0	0.00	1.0e+00	ALDH2 MSH6 SDK1
Systolic Blood Pressure	6.03	4	2	4.4	-0.16	8.4e-01	ALDH2 CADM2 NOB1 SDK1
Smoking Status	15.86	5	4	8.9	0.99	1.9e-03	CADM2 GTF3C6 MSH6 NOB1 SDK1
Allergy or Eczema	2.38	2	0	0.0	0.00	1.0e+00	ALDH2 EFNA1
Cardiovascular Disease	3.19	1	1	2.2	0.00	1.0e+00	ALDH2
Hypothyroidism (self reported)	13.14	1	1	2.2	0.00	1.0e+00	ALDH2
Lung FEV1/FVC ratio	1.05	2	0	0.0	0.00	1.0e+00	ALDH2 MSH6
Lung FVC	3.20	4	2	4.4	0.21	7.9e-01	ALDH2 EFNA1 MSH6 NOB1
Neuroticism	2.18	1	0	0.0	0.00	1.0e+00	CADM2
Chronotype (morning person)	3.33	2	1	2.2	0.00	1.0e+00	ALDH2 SDK1
Hair Pigment	0.69	3	2	4.4	0.00	1.0e+00	ALDH2 EFNA1 MSH6
Tanning	1.56	3	1	2.2	0.00	1.0e+00	ALDH2 CADM2 EFNA1
Hand grip strength (left)	3.68	2	1	2.2	0.00	1.0e+00	CADM2 NOB1
Number of treatments/medications taken	2.44	1	0	0.0	0.00	1.0e+00	ALDH2
Frequency of depressed mood in last 2 weeks	2.22	1	0	0.0	0.00	1.0e+00	MSH6
Systolic blood pressure, automated reading	3.94	2	1	2.2	0.00	1.0e+00	ALDH2 CADM2
Angina	2.91	1	0	0.0	0.00	1.0e+00	NOB1
Medication: Co-codamol	1.50	1	0	0.0	0.00	1.0e+00	MSH6
Impedance of leg (right)	3.02	3	2	4.4	0.00	1.0e+00	CADM2 EFNA1 NOB1
Leg fat-free mass (left)	3.19	3	1	2.2	0.00	1.0e+00	ALDH2 CADM2 EFNA1
Trunk fat percentage	1.98	3	0	0.0	0.00	1.0e+00	EFNA1 GTF3C6 NOB1
Hand grip strength (right)	2.44	2	0	0.0	0.00	1.0e+00	CADM2 NOB1
Current tobacco smoking	3.97	2	0	0.0	0.00	1.0e+00	CADM2 GTF3C6
Maternal smoking around birth	4.30	2	0	0.0	0.00	1.0e+00	GTF3C6 SDK1
Fed-up feelings	2.76	1	0	0.0	0.00	1.0e+00	ALDH2
Frequency of unenthusiasm / disinterest in last 2 weeks	2.21	1	0	0.0	0.00	1.0e+00	ALDH2
Taking other prescription medications	3.80	1	0	0.0	0.00	1.0e+00	ALDH2
Age when periods started (menarche)	2.59	2	0	0.0	0.00	1.0e+00	MSH6 NOB1
Heel bone mineral density (BMD) T-score, automated (left)	1.39	1	0	0.0	0.00	1.0e+00	EFNA1
High blood pressure	3.22	1	1	2.2	0.00	1.0e+00	ALDH2
Hayfever, allergic rhinitis or eczema	2.24	2	0	0.0	0.00	1.0e+00	ALDH2 EFNA1
Diverticular disease/diverticulitis (self-reported)	2.21	1	0	0.0	0.00	1.0e+00	ALDH2
Medication: Atenolol	3.86	1	0	0.0	0.00	1.0e+00	ALDH2
Medication: Levothyroxine sodium	11.27	1	1	2.2	0.00	1.0e+00	ALDH2
Body mass index (BMI)	4.01	5	1	2.2	0.45	4.5e-01	ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Impedance of leg (left)	3.10	4	2	4.4	-0.16	8.4e-01	CADM2 EFNA1 NOB1 SDK1
Leg predicted mass (left)	3.16	3	1	2.2	0.00	1.0e+00	ALDH2 CADM2 EFNA1
Trunk fat mass	2.51	5	0	0.0	0.30	6.2e-01	ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Waist circumference	3.11	4	1	2.2	0.63	3.7e-01	ALDH2 CADM2 GTF3C6 NOB1
Past tobacco smoking	21.92	7	6	13.3	-0.99	7.1e-06	ALDH2 CADM2 EFNA1 GTF3C6 MSH6 NOB1 SDK1
Nervous feelings	6.72	2	1	2.2	0.00	1.0e+00	CADM2 MSH6
Frequency of tenseness / restlessness in last 2 weeks	3.04	1	0	0.0	0.00	1.0e+00	ALDH2
Had other major operations	1.68	1	0	0.0	0.00	1.0e+00	SDK1
Forced vital capacity (FVC)	1.82	2	0	0.0	0.00	1.0e+00	MSH6 NOB1
Mouth/teeth dental problems	2.98	1	1	2.2	0.00	1.0e+00	EFNA1
Heart attack	3.69	2	0	0.0	0.00	1.0e+00	ALDH2 NOB1
Allergy	1.82	1	0	0.0	0.00	1.0e+00	EFNA1
Diabetes (self-reported)	2.52	1	0	0.0	0.00	1.0e+00	NOB1
Illnesses of siblings	1.69	1	0	0.0	0.00	1.0e+00	ALDH2
Neuroticism score	1.86	1	0	0.0	0.00	1.0e+00	CADM2
Weight	3.55	4	2	4.4	0.20	8.0e-01	ALDH2 CADM2 EFNA1 GTF3C6
Impedance of arm (right)	4.16	3	1	2.2	0.00	1.0e+00	ALDH2 CADM2 MSH6
Arm fat percentage (right)	2.74	4	0	0.0	0.54	4.6e-01	CADM2 EFNA1 GTF3C6 NOB1
Trunk fat-free mass	3.14	2	2	4.4	0.00	1.0e+00	ALDH2 CADM2
Hip circumference	3.18	2	2	4.4	0.00	1.0e+00	ALDH2 CADM2
Father's age at death	1.84	1	0	0.0	0.00	1.0e+00	ALDH2
Worrier / anxious feelings	7.14	2	1	2.2	0.00	1.0e+00	CADM2 GTF3C6
Frequency of tiredness / lethargy in last 2 weeks	1.99	1	0	0.0	0.00	1.0e+00	ALDH2
Number of live births	3.92	1	1	2.2	0.00	1.0e+00	CADM2
Forced expiratory volume in 1-second (FEV1)	1.85	1	0	0.0	0.00	1.0e+00	NOB1
Qualifications: A levels/AS levels or equivalent	2.26	2	0	0.0	0.00	1.0e+00	CADM2 MSH6
Mouth/teeth dental problems: Dentures	3.38	1	1	2.2	0.00	1.0e+00	EFNA1
Medication: Ibuprofen (e.g. Nurofen)	1.87	1	0	0.0	0.00	1.0e+00	ALDH2
Medication: Cholesterol lowering	1.93	1	0	0.0	0.00	1.0e+00	NOB1
Medication: Lansoprazole	2.83	1	0	0.0	0.00	1.0e+00	ALDH2
Forced expiratory volume in 1-second (FEV1), Best measure	1.92	1	0	0.0	0.00	1.0e+00	NOB1
Impedance of arm (left)	4.39	2	1	2.2	0.00	1.0e+00	ALDH2 CADM2
Arm fat mass (right)	3.49	5	1	2.2	0.35	5.6e-01	ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Trunk predicted mass	3.15	2	2	4.4	0.00	1.0e+00	ALDH2 CADM2
Standing height	0.48	1	0	0.0	0.00	1.0e+00	ALDH2
Tense / 'highly strung'	2.58	1	0	0.0	0.00	1.0e+00	CADM2
Seen doctor (GP) for nerves, anxiety, tension or depression	1.59	1	0	0.0	0.00	1.0e+00	CADM2
Hair/balding pattern: Pattern 4	2.00	2	0	0.0	0.00	1.0e+00	EFNA1 MSH6
Birth weight of first child	3.41	1	1	2.2	0.00	1.0e+00	ALDH2
Ever highly irritable/argumentative for 2 days	1.97	1	0	0.0	0.00	1.0e+00	ALDH2
Qualifications: O levels/GCSEs or equivalent	1.42	1	0	0.0	0.00	1.0e+00	CADM2
Blood clot in the leg (DVT)	3.09	1	0	0.0	0.00	1.0e+00	ALDH2
Headache pain in last month	1.99	1	0	0.0	0.00	1.0e+00	ALDH2
Medication for cholesterol, blood pressure or diabetes	2.17	1	0	0.0	0.00	1.0e+00	ALDH2
Gout (self-reported)	3.77	2	0	0.0	0.00	1.0e+00	ALDH2 EFNA1
Hypothyroidism/myxoedema (self-reported)	11.16	1	1	2.2	0.00	1.0e+00	ALDH2
Birth weight	2.59	1	1	2.2	0.00	1.0e+00	ALDH2
High blood pressure (siblings)	2.06	1	0	0.0	0.00	1.0e+00	ALDH2
Forced vital capacity (FVC), Best measure	2.01	2	0	0.0	0.00	1.0e+00	MSH6 NOB1
Body fat percentage	2.04	4	0	0.0	0.63	3.7e-01	CADM2 EFNA1 GTF3C6 NOB1
Leg fat percentage (right)	2.28	2	0	0.0	0.00	1.0e+00	CADM2 GTF3C6
Arm fat-free mass (right)	3.92	2	2	4.4	0.00	1.0e+00	ALDH2 CADM2
Comparative body size at age 10	3.51	1	1	2.2	0.00	1.0e+00	CADM2
Number of full brothers	3.62	1	0	0.0	0.00	1.0e+00	CADM2
Worry too long after embarrassment	2.57	1	0	0.0	0.00	1.0e+00	CADM2
Wheeze or whistling in the chest in last year	2.11	1	0	0.0	0.00	1.0e+00	EFNA1
Number of children fathered	5.56	1	1	2.2	0.00	1.0e+00	CADM2
Qualifications: College or University degree	2.73	2	1	2.2	0.00	1.0e+00	CADM2 SDK1
Medication for pain relief, constipation, heartburn	1.50	1	0	0.0	0.00	1.0e+00	GTF3C6
Medication: Blood pressure	2.90	1	0	0.0	0.00	1.0e+00	ALDH2
Angina (self-reported)	2.88	1	0	0.0	0.00	1.0e+00	NOB1
Medication: Allopurinol	3.13	2	0	0.0	0.00	1.0e+00	ALDH2 EFNA1
Mean time to correctly identify matches	3.62	1	1	2.2	0.00	1.0e+00	ALDH2
Heart disease (mother)	2.78	1	0	0.0	0.00	1.0e+00	ALDH2
Reproduciblity of spirometry measurement using ERS/ATS criteria	2.03	1	0	0.0	0.00	1.0e+00	EFNA1
Whole body fat mass	3.04	5	1	2.2	0.36	5.5e-01	ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Leg fat mass (right)	3.63	4	1	2.2	0.63	3.7e-01	ALDH2 CADM2 GTF3C6 NOB1
Arm predicted mass (right)	3.87	2	2	4.4	0.00	1.0e+00	ALDH2 CADM2
Pulse rate, automated reading	1.91	1	1	2.2	0.00	1.0e+00	MSH6
Alcohol intake frequency.	2.39	1	0	0.0	0.00	1.0e+00	CADM2
Comparative height size at age 10	1.14	1	1	2.2	0.00	1.0e+00	ALDH2
Number of full sisters	4.06	1	1	2.2	0.00	1.0e+00	CADM2
Suffer from 'nerves'	4.35	1	1	2.2	0.00	1.0e+00	CADM2
Qualifications: NVQ or HND or HNC or equivalent	4.46	2	0	0.0	0.00	1.0e+00	ALDH2 SDK1
Hypertension (Self-reported)	2.69	1	1	2.2	0.00	1.0e+00	ALDH2
Illnesses of father: Heart disease	2.85	1	0	0.0	0.00	1.0e+00	ALDH2
Forced expiratory volume in 1-second (FEV1), predicted	1.18	1	0	0.0	0.00	1.0e+00	SDK1
Whole body fat-free mass	3.26	2	2	4.4	0.00	1.0e+00	ALDH2 CADM2
Leg fat-free mass (right)	2.99	3	1	2.2	0.00	1.0e+00	ALDH2 CADM2 EFNA1
Arm fat percentage (left)	2.75	4	0	0.0	0.54	4.6e-01	CADM2 EFNA1 GTF3C6 NOB1
Mood swings	1.86	1	0	0.0	0.00	1.0e+00	ALDH2
Loneliness, isolation	2.86	1	0	0.0	0.00	1.0e+00	ALDH2
Long-standing illness, disability or infirmity	3.65	1	0	0.0	0.00	1.0e+00	GTF3C6
Diabetes diagnosed by doctor	2.77	1	0	0.0	0.00	1.0e+00	NOB1
Ever had stillbirth, spontaneous miscarriage or termination	2.56	1	0	0.0	0.00	1.0e+00	CADM2
Qualifications: nursing, teaching	2.85	2	0	0.0	0.00	1.0e+00	CADM2 SDK1
Mouth/teeth dental problems: Mouth ulcers	1.75	1	0	0.0	0.00	1.0e+00	CADM2
Medication for cholesterol	2.48	1	0	0.0	0.00	1.0e+00	ALDH2
Back pain experienced in last month	3.17	1	0	0.0	0.00	1.0e+00	ALDH2
Medication: Gliclazide	2.34	1	0	0.0	0.00	1.0e+00	EFNA1
Illnesses of father: None of the above (group 1)	1.87	1	0	0.0	0.00	1.0e+00	ALDH2
Smoking status: Current	4.63	3	0	0.0	0.00	1.0e+00	ALDH2 CADM2 GTF3C6
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.43	1	0	0.0	0.00	1.0e+00	NOB1
Whole body water mass	3.31	2	2	4.4	0.00	1.0e+00	ALDH2 CADM2
Leg predicted mass (right)	2.94	3	1	2.2	0.00	1.0e+00	ALDH2 CADM2 EFNA1
Arm fat mass (left)	3.71	5	1	2.2	0.38	5.2e-01	ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Number of self-reported non-cancer illnesses	3.26	1	0	0.0	0.00	1.0e+00	ALDH2
Miserableness	1.45	1	0	0.0	0.00	1.0e+00	EFNA1
Wears glasses or contact lenses	3.14	1	0	0.0	0.00	1.0e+00	CADM2
Financial situation satisfaction	3.62	2	0	0.0	0.00	1.0e+00	CADM2 NOB1
Commuting to job workplace: Public transport	2.69	1	0	0.0	0.00	1.0e+00	CADM2
Medication: Blood pressure	2.93	1	1	2.2	0.00	1.0e+00	ALDH2
High cholesterol (Self-reported)	1.95	1	0	0.0	0.00	1.0e+00	EFNA1
Medication: Bendroflumethiazide	1.31	1	0	0.0	0.00	1.0e+00	ALDH2
Medication: Atorvastatin	2.01	1	0	0.0	0.00	1.0e+00	EFNA1
Alcohol drinker status: Never	2.84	1	0	0.0	0.00	1.0e+00	CADM2
Ever smoked	16.14	7	3	6.7	0.98	7.2e-05	ALDH2 CADM2 EFNA1 GTF3C6 MSH6 NOB1 SDK1
Basal metabolic rate	3.44	2	2	4.4	0.00	1.0e+00	ALDH2 CADM2
Leg fat percentage (left)	2.33	2	0	0.0	0.00	1.0e+00	CADM2 GTF3C6
Arm fat-free mass (left)	4.09	2	2	4.4	0.00	1.0e+00	ALDH2 CADM2
Average weekly beer plus cider intake	3.49	1	0	0.0	0.00	1.0e+00	CADM2
Risk taking	10.15	2	1	2.2	0.00	1.0e+00	CADM2 NOB1
Age started oral contraceptive pill	4.04	1	0	0.0	0.00	1.0e+00	CADM2
Diastolic blood pressure, automated reading	4.89	2	1	2.2	0.00	1.0e+00	ALDH2 EFNA1
Vascular/heart problems diagnosed by doctor	3.16	1	1	2.2	0.00	1.0e+00	ALDH2
Pain experienced in last month	3.60	2	0	0.0	0.00	1.0e+00	ALDH2 EFNA1
Heart attack/myocardial infarction (self-reported)	3.59	2	0	0.0	0.00	1.0e+00	ALDH2 NOB1
Deep venous thrombosis (DVT) (self-reported)	3.00	1	0	0.0	0.00	1.0e+00	ALDH2
Impedance of whole body	3.65	2	1	2.2	0.00	1.0e+00	ALDH2 CADM2
Leg fat mass (left)	3.67	4	1	2.2	0.65	3.5e-01	ALDH2 CADM2 GTF3C6 NOB1
Arm predicted mass (left)	4.04	2	2	4.4	0.00	1.0e+00	ALDH2 CADM2

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	1	0.029	1.5
GTEx	Adipose Visceral Omentum	0	0.000	1.6
GTEx	Adrenal Gland	0	0.000	1.5
GTEx	Artery Aorta	0	0.000	1.5
GTEx	Artery Coronary	0	0.000	1.6
GTEx	Artery Tibial	0	0.000	1.5
GTEx	Brain Caudate basal ganglia	0	0.000	1.5
GTEx	Brain Cerebellar Hemisphere	0	0.000	1.7
GTEx	Brain Cerebellum	4	0.202	1.7
GTEx	Brain Cortex	0	0.000	1.6
GTEx	Brain Frontal Cortex BA9	0	0.000	1.6
GTEx	Brain Hippocampus	0	0.000	1.6
GTEx	Brain Hypothalamus	1	0.169	1.7
GTEx	Brain Nucleus accumbens basal ganglia	0	0.000	1.5
GTEx	Brain Putamen basal ganglia	0	0.000	1.4
GTEx	Breast Mammary Tissue	0	0.000	1.6
GTEx	Breast Mammary Tissue (Male)	0	0.000	1.6
GTEx	Breast Mammary Tissue (Female)	0	0.000	1.5
GTEx	Cells EBV-transformed lymphocytes	0	0.000	1.6
GTEx	Cells Transformed fibroblasts	0	0.000	1.5
GTEx	Colon Sigmoid	0	0.000	1.6
GTEx	Colon Transverse	1	0.048	1.6
GTEx	Esophagus Gastroesophageal Junction	0	0.000	1.6
GTEx	Esophagus Mucosa	0	0.000	1.5
GTEx	Esophagus Muscularis	1	0.031	1.6
GTEx	Heart Atrial Appendage	0	0.000	1.5
GTEx	Heart Left Ventricle	0	0.000	1.6
GTEx	Liver	0	0.000	1.5
GTEx	Lung	0	0.000	1.6
GTEx	Muscle Skeletal	1	0.035	1.6
GTEx	Nerve Tibial	0	0.000	1.5
GTEx	Ovary	0	0.000	1.6
GTEx	Pancreas	0	0.000	1.7
GTEx	Pituitary	0	0.000	1.6
GTEx	Prostate	0	0.000	1.7
GTEx	Skin Not Sun Exposed Suprapubic	0	0.000	1.6
GTEx	Skin Sun Exposed Lower leg	1	0.027	1.6
GTEx	Small Intestine Terminal Ileum	0	0.000	1.6
GTEx	Spleen	0	0.000	1.6
GTEx	Stomach	1	0.069	1.5
GTEx	Testis	0	0.000	1.6
GTEx	Thyroid	0	0.000	1.5
GTEx	Uterus	0	0.000	1.6
GTEx	Vagina	0	0.000	1.5
GTEx	Whole Blood	0	0.000	1.6
METSIM	Adipose	2	0.043	1.5
NTR	Blood	0	0.000	1.5
ROSMAP	Brain Pre-frontal Cortex	0	0.000	1.5
YFS	Blood	0	0.000	1.5
CommonMind	Brain Pre-frontal Cortex	1	0.019	1.5
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Breast Invasive Carcinoma	0	0.000	1.5
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Colon Adenocarcinoma	0	0.000	1.4
The Cancer Genome Atlas	Esophageal Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Glioblastoma Multiforme	0	0.000	1.5
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Brain Lower Grade Glioma	2	0.046	1.5
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Lung Adenocarcinoma	1	0.034	1.4
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	1	0.040	1.4
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	0	0.000	1.5
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	0	0.000	1.4
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	1	0.075	1.5
The Cancer Genome Atlas	Prostate Adenocarcinoma	0	0.000	1.4
The Cancer Genome Atlas	Rectum Adenocarcinoma	0	0.000	1.4
The Cancer Genome Atlas	Soft Tissue Sarcoma	0	0.000	1.4
The Cancer Genome Atlas	Skin Cutaneous Melanoma	0	0.000	1.4
The Cancer Genome Atlas	Stomach Adenocarcinoma	0	0.000	1.3
The Cancer Genome Atlas	Testicular Germ Cell Tumors	0	0.000	1.4
The Cancer Genome Atlas	Thyroid Carcinoma	1	0.019	1.4
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	0	0.000	1.2